Jeffrey A. Meckler - 26 Jan 2022 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
CEO and Director, Director
Signature
/s/ Jeffrey Meckler
Issuer symbol
INDP
Transactions as of
26 Jan 2022
Net transactions value
$0
Form type
4
Filing time
28 Jan 2022, 15:30:59 UTC
Previous filing
19 Nov 2021
Next filing
12 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +200,000 $0.000000 200,000 26 Jan 2022 Common Stock 200,000 $4.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to one-third of the total shares on January 26, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.